Last 7 days
-1.9%
Last 30 days
-12.6%
Last 90 days
-8.4%
Trailing 12 Months
-22.0%
Year | Q1 | Q2 | Q3 | Q4 |
---|---|---|---|---|
2023 | 183.0B | 186.1B | 189.9B | 0 |
2022 | 177.1B | 179.5B | 180.5B | 180.5B |
2021 | 162.9B | 166.8B | 170.1B | 174.1B |
2020 | 154.1B | 154.5B | 156.9B | 160.4B |
2019 | 75.2B | 102.5B | 129.6B | 153.6B |
2018 | 42.8B | 43.9B | 45.0B | 48.6B |
2017 | 40.3B | 40.8B | 41.3B | 41.8B |
2016 | 0 | 0 | 0 | 39.8B |
Datesorted ascending | Name | Buy/Sell | $ Value | Avg. Price | # Shares | Title |
---|---|---|---|---|---|---|
Sep 14, 2023 | eder noelle k | sold (taxes) | -257,359 | 285 | -902 | evp, technology & operations |
Sep 01, 2023 | brailer david j | sold (taxes) | -56,186 | 278 | -202 | evp & chief health officer |
Aug 30, 2023 | ryan cynthia | acquired | 64,724 | 149 | 434 | evp, chro |
Aug 29, 2023 | ryan cynthia | acquired | 449,195 | 149 | 3,012 | evp, chro |
Aug 29, 2023 | ryan cynthia | sold | -1,063,400 | 282 | -3,768 | evp, chro |
Aug 21, 2023 | jones nicole s | sold | -2,164,770 | 276 | -7,819 | evp, general counsel |
Aug 08, 2023 | agoglia hoeltzel mary t | sold | -3,564,750 | 291 | -12,250 | svp tax & chief acct. officer |
Aug 08, 2023 | agoglia hoeltzel mary t | acquired | 351,158 | 78.035 | 4,500 | svp tax & chief acct. officer |
Aug 03, 2023 | evanko brian c | acquired | 44,479 | 78.035 | 570 | evp, chief financial officer |
Aug 02, 2023 | evanko brian c | acquired | 180,027 | 78.035 | 2,307 | evp, chief financial officer |
Datesorted ascending | Fund Name | Type | % Chg | $ Change | $ Held | % Portfolio |
---|---|---|---|---|---|---|
Dec 06, 2023 | CITIGROUP INC | reduced | -4.08 | -1,601,130 | 70,994,100 | 0.05% |
Dec 06, 2023 | VisionPoint Advisory Group, LLC | added | 112 | 16,000 | 29,749 | 0.01% |
Dec 06, 2023 | Fragasso Group Inc. | added | 2.64 | 13,765 | 311,167 | 0.03% |
Dec 06, 2023 | Raleigh Capital Management Inc. | added | 25.53 | 3,750 | 17,003 | 0.01% |
Dec 05, 2023 | Advisory Resource Group | added | 2.34 | 134,678 | 3,241,760 | 0.88% |
Dec 04, 2023 | TUCKER ASSET MANAGEMENT LLC | unchanged | - | 16.00 | 858 | -% |
Dec 01, 2023 | PFS Partners, LLC | added | 0.4 | 1,576 | 70,832 | 0.06% |
Dec 01, 2023 | B. Riley Wealth Advisors, Inc. | reduced | -60.15 | -3,054,060 | 2,089,640 | 0.06% |
Nov 30, 2023 | Neo Ivy Capital Management | new | - | 203,000 | 203,000 | 0.09% |
Nov 30, 2023 | Modera Wealth Management, LLC | added | 13.86 | 73,898 | 533,521 | 0.01% |
Date Filed | Name of Filer | Percent of Class | No. of Shares | Form Type | |
---|---|---|---|---|---|
Feb 14, 2023 | dodge & cox | 3.8% | 11,548,557 | SC 13G/A | |
Feb 14, 2023 | price t rowe associates inc /md/ | 4.5% | 13,656,608 | SC 13G/A | |
Feb 09, 2023 | fmr llc | - | 0 | SC 13G | |
Feb 09, 2023 | vanguard group inc | 8.37% | 25,583,766 | SC 13G/A | |
Feb 07, 2023 | blackrock inc. | 9.0% | 27,469,496 | SC 13G | |
Feb 14, 2022 | dodge & cox | 5.3% | 17,484,197 | SC 13G | |
Feb 14, 2022 | price t rowe associates inc /md/ | 5.4% | 17,961,332 | SC 13G/A | |
Feb 09, 2022 | vanguard group inc | 7.88% | 26,120,848 | SC 13G/A | |
Feb 09, 2022 | fmr llc | - | 0 | SC 13G/A | |
Feb 03, 2022 | blackrock inc. | 8.9% | 29,587,276 | SC 13G/A |
Date Filed | Form Type | Document | |
---|---|---|---|
Dec 04, 2023 | 8-K | Current Report | |
Dec 04, 2023 | 4 | Insider Trading | |
Dec 04, 2023 | 4 | Insider Trading | |
Nov 02, 2023 | 8-K | Current Report | |
Nov 02, 2023 | 10-Q | Quarterly Report | |
Oct 13, 2023 | 144 | Notice of Insider Sale Intent | |
Sep 18, 2023 | 4 | Insider Trading | |
Sep 15, 2023 | 8-K | Current Report | |
Sep 11, 2023 | 8-K | Current Report | |
Sep 05, 2023 | 4 | Insider Trading |
Name | Mkt Capsorted ascending | Revenue | Price %, 1M | Returns, 1Y | P/E | P/S | Rev 1-Yr | Inc 1-Yr |
---|---|---|---|---|---|---|---|---|
LARGE-CAP | ||||||||
UNH | 507.1B | 360.0B | 1.94% | 1.34% | 23.38 | 1.41 | 14.24% | 11.62% |
CVS | 95.3B | 347.8B | 5.35% | -27.64% | 10.94 | 0.27 | 10.34% | 159.11% |
CI | 91.1B | 189.9B | -12.60% | -22.05% | 13.64 | 1.92 | 5.24% | 22.27% |
HCA | 68.3B | 63.2B | 8.96% | 6.67% | 11.95 | 1.08 | 5.62% | 6.32% |
CNC | 39.7B | 150.1B | 3.44% | -15.03% | 16.23 | 0.26 | 6.04% | 21.35% |
MID-CAP | ||||||||
DVA | 9.7B | 11.9B | 32.01% | 41.29% | 15.86 | 0.81 | 2.36% | -10.41% |
UHS | 9.4B | 14.0B | 3.25% | 4.87% | 13.92 | 0.67 | 6.03% | -8.61% |
CHE | 8.6B | 2.2B | -1.50% | 10.15% | 35.21 | 3.87 | 4.50% | -6.69% |
ACHC | 6.6B | 2.9B | -3.11% | -12.16% | -359.29 | 2.29 | 13.16% | -106.47% |
AMN | 2.6B | 4.1B | 9.38% | -42.09% | 9.26 | 0.63 | -25.26% | -41.25% |
SMALL-CAP | ||||||||
AMEH | 1.6B | 1.3B | 13.24% | 13.97% | 34.75 | 1.17 | 27.06% | -27.04% |
ADUS | 1.4B | 1.0B | 6.69% | -15.76% | 25.11 | 1.41 | 10.84% | 30.19% |
BKD | 982.6M | 3.0B | 18.37% | 74.00% | -7.96 | 0.33 | 6.98% | 58.07% |
BEAT | 36.3M | - | 2.22% | -73.51% | -2.51 | - | - | -27.68% |
AMS | 15.3M | 20.7M | 7.02% | -13.27% | 52.66 | 0.74 | 6.53% | -78.75% |
Income Statement (Quarterly) | (In Millions) | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Description | (%) Q/Q | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 | 2018Q4 | 2018Q3 |
Revenue | 1.0% | 49,048 | 48,586 | 46,517 | 45,752 | 45,280 | 45,478 | 44,006 | 45,688 | 44,288 | 43,131 | 40,971 | 41,712 | 40,955 | 39,265 | 38,469 | 38,245 | 38,556 | 38,819 | 37,946 | 14,300 | 11,457 |
S&GA Expenses | 10.3% | 3,788 | 3,434 | 3,538 | 3,491 | 3,148 | 3,264 | 3,275 | 3,662 | 3,093 | 2,996 | 3,279 | 3,966 | 3,301 | 3,407 | 3,398 | 3,957 | 3,413 | 3,380 | 3,303 | 3,480 | 2,872 |
EBITDA Margin | -100.0% | - | 0.07* | 0.07* | 0.07* | 0.07* | 0.18* | 0.06* | 0.06* | 0.09* | 0.09* | 0.09* | 0.09* | 0.07* | 0.07* | 0.07* | 0.08* | 0.08* | - | - | - | - |
Interest Expenses | 24.8% | 387 | 310 | 322 | 306 | 308 | 307 | 308 | 303 | 311 | 308 | 331 | 327 | 369 | 348 | 395 | 388 | 392 | 488 | 377 | 100 | 40.00 |
Income Taxes | 4.5% | 391 | 374 | 295 | 129 | 713 | 411 | 355 | 179 | 424 | 422 | 342 | 1,236 | 406 | 529 | 208 | 277 | 409 | 348 | 416 | 81.00 | 259 |
Earnings Before Taxes | -2.3% | 1,840 | 1,884 | 1,601 | 1,321 | 3,491 | 1,981 | 1,567 | 1,312 | 2,059 | 1,898 | 1,513 | 5,378 | 1,804 | 2,289 | 1,397 | 1,261 | 1,763 | 1,758 | 1,788 | 228 | 1,033 |
EBT Margin | -100.0% | - | 0.04* | 0.05* | 0.05* | 0.05* | 0.15* | 0.04* | 0.04* | 0.06* | 0.06* | 0.07* | 0.07* | 0.04* | 0.04* | 0.04* | 0.04* | 0.04* | - | - | - | - |
Net Income | -100.0% | - | 1,510 | 1,306 | 1,192 | 2,778 | 1,570 | 1,212 | 1,133 | 1,635 | 1,476 | 1,171 | 4,142 | 1,398 | 1,760 | 1,189 | 977 | 1,354 | 1,410 | 1,372 | 144 | 772 |
Net Income Margin | -100.0% | - | 0.04* | 0.04* | 0.04* | 0.04* | 0.12* | 0.03* | 0.03* | 0.05* | 0.05* | 0.05* | 0.05* | 0.03* | 0.03* | 0.03* | 0.03* | 0.03* | - | - | - | - |
Free Cashflow | -100.0% | - | 2,492 | 5,028 | 2,099 | 3,283 | 1,244 | 2,030 | 4,275 | 2,119 | -296 | 783 | 3,984 | 585 | 2,964 | 1,577 | 2,483 | 2,218 | - | - | - | - |
Balance Sheet | (In Millions) | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Description | (%) Q/Q | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 | 2018Q4 | 2018Q3 |
Assets | -0.3% | 149,645 | 150,054 | 147,976 | 143,885 | 144,209 | 152,630 | 152,610 | 154,889 | 154,251 | 154,207 | 152,081 | 155,451 | 160,044 | 159,628 | 154,711 | 155,774 | 154,847 | 154,401 | 154,348 | 153,226 | 130,359 |
Current Assets | -0.6% | 34,518 | 34,711 | 32,027 | 30,122 | 30,170 | 37,422 | 35,393 | 36,134 | 25,487 | 25,011 | 25,554 | 27,799 | 34,557 | 34,880 | 30,877 | 29,845 | 21,168 | 20,709 | 21,136 | 20,430 | - |
Cash Equivalents | -10.8% | 8,546 | 9,585 | 7,935 | 5,924 | 7,079 | 4,468 | 4,469 | 5,081 | 3,540 | 3,878 | 6,544 | 10,245 | 5,406 | 7,185 | 4,452 | 4,668 | 4,577 | 3,610 | 4,976 | 3,855 | 24,032 |
Inventory | -2.2% | 4,416 | 4,514 | 4,211 | 4,777 | 4,017 | 3,781 | 3,500 | 3,722 | 3,020 | 3,042 | 2,919 | 3,165 | 2,657 | 2,712 | 2,565 | 2,661 | 2,160 | 2,298 | 2,382 | 2,821 | - |
Net PPE | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 4,417 | 4,448 | 4,538 | 4,523 | 4,562 | - |
Goodwill | 0.0% | 45,810 | 45,811 | 45,811 | 45,811 | 45,807 | 45,810 | 45,804 | 45,811 | 46,056 | 46,063 | 44,635 | 44,648 | 44,685 | 44,590 | 44,584 | 44,602 | 44,462 | 44,449 | 44,537 | 44,505 | - |
Liabilities | -0.6% | 103,879 | 104,528 | 103,380 | 99,131 | 99,076 | 106,663 | 106,446 | 107,705 | 106,768 | 105,440 | 103,867 | 105,065 | 111,946 | 112,223 | 109,590 | 110,395 | 110,114 | 110,552 | 111,897 | 112,154 | 96,115 |
Current Liabilities | -0.6% | 47,059 | 47,345 | 44,727 | 41,225 | 41,115 | 45,218 | 43,662 | 43,572 | 36,340 | 34,711 | 33,470 | 36,022 | 43,886 | 42,179 | 40,380 | 40,138 | 34,447 | 31,867 | 32,969 | 31,895 | - |
Long Term Debt | -0.1% | 28,094 | 28,115 | 29,124 | 28,100 | 28,090 | 30,984 | 31,013 | 31,125 | 31,609 | 31,606 | 31,568 | 29,545 | 29,537 | 31,774 | 32,147 | 31,893 | 34,041 | 36,885 | 37,571 | 39,523 | - |
Shareholder's Equity | 0.6% | 45,702 | 45,445 | 44,518 | 44,675 | 45,041 | 45,701 | 46,145 | 46,976 | 47,427 | 48,716 | 48,155 | 50,328 | 48,039 | 47,371 | 45,086 | 45,344 | 44,699 | 43,818 | 42,413 | 41,035 | 15,555 |
Retained Earnings | 2.6% | 40,982 | 39,936 | 38,841 | 37,940 | 37,041 | 34,626 | 33,420 | 32,593 | 31,803 | 30,513 | 29,389 | 28,575 | 24,440 | 23,052 | 21,298 | 20,162 | 19,185 | 17,834 | 16,426 | 15,088 | - |
Additional Paid-In Capital | 0.4% | 30,563 | 30,436 | 30,332 | 30,233 | 29,395 | 29,930 | 29,736 | 29,574 | 29,077 | 29,403 | 29,254 | 28,975 | 28,777 | 28,699 | 28,554 | 28,306 | 28,115 | 27,891 | 27,855 | 27,751 | - |
Minority Interest | -42.1% | 11.00 | 19.00 | 16.00 | 13.00 | 42.00 | 30.00 | 22.00 | 18.00 | 12.00 | 7.00 | 6.00 | 7.00 | 7.00 | 5.00 | 7.00 | 6.00 | 3.00 | 3.00 | 5.00 | 7.00 | - |
Cashflow (Quarterly) | (In Millions) | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Description | (%) Q/Q | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 | 2018Q4 | 2018Q3 |
Cashflow From Operations | 13.4% | 2,826 | 2,492 | 5,028 | 2,099 | 3,283 | 1,244 | 2,030 | 4,275 | 2,119 | -296 | 1,093 | 4,294 | 895 | 3,274 | 1,887 | 2,793 | 2,461 | 1,039 | 3,192 | 126 | 624 |
Cashflow From Investing | -222.9% | -1,337 | -414 | -2,983 | -616 | 4,446 | -408 | -324 | 123 | -710 | -2,307 | -717 | 4,420 | -938 | -237 | -269 | -271 | -304 | -634 | 475 | -24,704 | 125 |
Cashflow From Financing | -491.3% | -2,572 | -435 | -37.00 | -2,636 | -5,517 | -916 | -2,171 | -2,371 | -1,728 | -62.00 | -4,051 | -4,721 | -1,682 | -312 | -1,818 | -1,707 | -1,173 | -1,773 | -2,534 | 4,400 | 19,657 |
Dividend Payments | 0% | 362 | 362 | 368 | 334 | 341 | 352 | 357 | 324 | 330 | 342 | 345 | - | - | 15.00 | - | - | - | - | - | - | - |
Buy Backs | 305.2% | 624 | 154 | 962 | 1,733 | 3,500 | 1,006 | 1,368 | 1,421 | 2,611 | 916 | 2,794 | 1,690 | 1,028 | 368 | 956 | 447 | 674 | 404 | 462 | 32.00 | - |
Consolidated Statements of Income - USD ($) $ in Millions | 3 Months Ended | 9 Months Ended | ||||||
---|---|---|---|---|---|---|---|---|
Sep. 30, 2023 | Sep. 30, 2022 | [1] | Sep. 30, 2023 | Sep. 30, 2022 | [1] | |||
Revenues | ||||||||
Premiums | $ 10,998 | $ 9,586 | $ 33,062 | $ 30,368 | ||||
Net investment income | 321 | 204 | 876 | 943 | ||||
TOTAL REVENUES | 49,048 | 45,281 | 144,151 | 134,765 | ||||
Benefits and expenses | ||||||||
Pharmacy and other service costs | 33,639 | 31,777 | 98,540 | 92,740 | ||||
Medical costs and other benefit expenses | 8,927 | 7,751 | 27,007 | 24,215 | ||||
Selling, general and administrative expenses | 3,788 | 3,151 | 10,760 | 9,690 | ||||
Amortization of acquired intangible assets | 454 | 460 | 1,368 | 1,419 | ||||
TOTAL BENEFITS AND EXPENSES | 46,808 | 43,139 | 137,675 | 128,064 | ||||
Income from operations | 2,240 | 2,142 | 6,476 | 6,701 | ||||
Interest expense and other | (365) | (304) | (1,086) | (904) | ||||
(Loss) gain on sale of businesses | (21) | 1,735 | (21) | 1,735 | ||||
Net realized investment losses | (14) | (82) | (44) | (493) | ||||
Income before income taxes | 1,840 | 3,491 | 5,325 | 7,039 | ||||
TOTAL INCOME TAXES | 391 | 713 | 1,060 | 1,479 | ||||
Net income | 1,449 | 2,778 | 4,265 | 5,560 | ||||
Less: Net income attributable to noncontrolling interests | 41 | 21 | 130 | 49 | ||||
SHAREHOLDERS' NET INCOME | $ 1,408 | $ 2,757 | $ 4,135 | $ 5,511 | ||||
Shareholders' net income per share | ||||||||
Basic (in dollars per share) | $ 4.79 | $ 9.07 | $ 14.03 | $ 17.64 | ||||
Diluted (in dollars per share) | $ 4.74 | $ 8.97 | $ 13.89 | $ 17.46 | ||||
Pharmacy revenues | ||||||||
Revenues | ||||||||
Revenues | $ 34,531 | $ 32,762 | $ 100,639 | $ 95,431 | ||||
Fees and other revenues | ||||||||
Revenues | ||||||||
Revenues | $ 3,198 | $ 2,729 | $ 9,574 | $ 8,023 | ||||
|
Consolidated Balance Sheets - USD ($) $ in Millions | Sep. 30, 2023 | Dec. 31, 2022 | [1] | ||||
---|---|---|---|---|---|---|---|
Assets | |||||||
Cash and cash equivalents | $ 8,497 | $ 5,924 | |||||
Investments | 1,046 | 905 | |||||
Accounts receivable, net | 19,083 | 17,218 | |||||
Inventories | 4,416 | 4,777 | |||||
Other current assets | 1,476 | 1,298 | |||||
Total current assets | 34,518 | 30,122 | |||||
Long-term investments | 18,974 | 16,288 | |||||
Reinsurance recoverables | 4,920 | 5,416 | |||||
Property and equipment | 3,924 | 3,774 | |||||
Goodwill | 45,810 | 45,811 | |||||
Other intangible assets | 31,324 | 32,492 | |||||
Other assets | 3,147 | 2,704 | |||||
Separate account assets | 7,028 | 7,278 | |||||
TOTAL ASSETS | 149,645 | 143,885 | |||||
Liabilities | |||||||
Current insurance and contractholder liabilities | 7,352 | 5,409 | |||||
Pharmacy and other service costs payable | 19,320 | 17,070 | |||||
Accounts payable | 7,673 | 7,775 | |||||
Accrued expenses and other liabilities | 9,668 | 7,978 | |||||
Short-term debt | 3,046 | 2,993 | |||||
Total current liabilities | 47,059 | 41,225 | |||||
Non-current insurance and contractholder liabilities | 11,286 | 11,976 | |||||
Deferred tax liabilities, net | 7,480 | 7,786 | |||||
Other non-current liabilities | 2,932 | 2,766 | |||||
Long-term debt | 28,094 | 28,100 | |||||
Separate account liabilities | 7,028 | 7,278 | |||||
TOTAL LIABILITIES | 103,879 | 99,131 | |||||
Contingencies — Note 16 | |||||||
Redeemable noncontrolling interests | 64 | 66 | |||||
Shareholders' equity | |||||||
Common stock | [2] | 4 | 4 | ||||
Additional paid-in capital | 30,563 | 30,233 | |||||
Accumulated other comprehensive loss | (2,119) | (1,658) | |||||
Retained earnings | 40,982 | 37,940 | |||||
Less: Treasury stock, at cost | (23,739) | (21,844) | |||||
TOTAL SHAREHOLDERS' EQUITY | 45,691 | 44,675 | |||||
Other noncontrolling interests | 11 | 13 | |||||
Total equity | 45,702 | 44,688 | |||||
Total liabilities and equity | $ 149,645 | $ 143,885 | |||||
|
CEO | Mr. David Michael Cordani |
---|---|
WEBSITE | www.cigna.com |
EMPLOYEES | 65535 |